UK Legislators Get Involved In NICE’s Methods Review
Executive Summary
A UK parliamentary panel examining a wide range of issues affecting the availability of new treatments on the National Health Service is collecting evidence on possible topics that might be covered under the upcoming review of the appraisal methods used by health technology assessment body NICE. NICE itself is not publicly consulting on the scope of the review.
You may also be interested in...
UK NICE Review Will Look At Criteria For Appraising Highly Specialized Products
The UK's HTA body, NICE, says a more scientific criteria should be used to decide how many products should be admitted to its program for evaluating highly specialized technologies.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.